![KappaBle fluorescent reporter mice enable dynamic and low-background single-cell detection of NF-κB activity in vivo | bioRxiv KappaBle fluorescent reporter mice enable dynamic and low-background single-cell detection of NF-κB activity in vivo | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/09/03/2021.09.02.458704/F4.large.jpg)
KappaBle fluorescent reporter mice enable dynamic and low-background single-cell detection of NF-κB activity in vivo | bioRxiv
![Frontiers | Human NF-κB1 Haploinsufficiency and Epstein–Barr Virus-Induced Disease—Molecular Mechanisms and Consequences | Immunology Frontiers | Human NF-κB1 Haploinsufficiency and Epstein–Barr Virus-Induced Disease—Molecular Mechanisms and Consequences | Immunology](https://www.frontiersin.org/files/Articles/325993/fimmu-08-01978-HTML/image_m/fimmu-08-01978-g001.jpg)
Frontiers | Human NF-κB1 Haploinsufficiency and Epstein–Barr Virus-Induced Disease—Molecular Mechanisms and Consequences | Immunology
![Cells | Free Full-Text | Aberrant Activation of NF-κB Signalling in Aggressive Lymphoid Malignancies | HTML Cells | Free Full-Text | Aberrant Activation of NF-κB Signalling in Aggressive Lymphoid Malignancies | HTML](https://www.mdpi.com/cells/cells-07-00189/article_deploy/html/images/cells-07-00189-g001.png)
Cells | Free Full-Text | Aberrant Activation of NF-κB Signalling in Aggressive Lymphoid Malignancies | HTML
![KappaBle fluorescent reporter mice enable dynamic and low-background single-cell detection of NF-κB activity in vivo | bioRxiv KappaBle fluorescent reporter mice enable dynamic and low-background single-cell detection of NF-κB activity in vivo | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/09/03/2021.09.02.458704/F2.large.jpg)
KappaBle fluorescent reporter mice enable dynamic and low-background single-cell detection of NF-κB activity in vivo | bioRxiv
![Early and late B-cell developmental impairment in nuclear factor kappa B, subunit 1–mutated common variable immunodeficiency disease - Journal of Allergy and Clinical Immunology Early and late B-cell developmental impairment in nuclear factor kappa B, subunit 1–mutated common variable immunodeficiency disease - Journal of Allergy and Clinical Immunology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/0f333037-f6f1-494d-b092-b837b2b26875/gr1_lrg.jpg)
Early and late B-cell developmental impairment in nuclear factor kappa B, subunit 1–mutated common variable immunodeficiency disease - Journal of Allergy and Clinical Immunology
![NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms. - Abstract - Europe PMC NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5382109/bin/nihms824859f1.jpg)
NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms. - Abstract - Europe PMC
![Bruton's Tyrosine Kinase Mediates NF-κB Activation and B Cell Survival by B Cell-Activating Factor Receptor of the TNF-R Family | The Journal of Immunology Bruton's Tyrosine Kinase Mediates NF-κB Activation and B Cell Survival by B Cell-Activating Factor Receptor of the TNF-R Family | The Journal of Immunology](https://www.jimmunol.org/content/jimmunol/179/6/3872/F5.large.jpg)
Bruton's Tyrosine Kinase Mediates NF-κB Activation and B Cell Survival by B Cell-Activating Factor Receptor of the TNF-R Family | The Journal of Immunology
![LSD1 Cooperates with Noncanonical NF-κB Signaling to Regulate Marginal Zone B Cell Development | The Journal of Immunology LSD1 Cooperates with Noncanonical NF-κB Signaling to Regulate Marginal Zone B Cell Development | The Journal of Immunology](https://www.jimmunol.org/content/jimmunol/203/7/1867/F1.large.jpg)
LSD1 Cooperates with Noncanonical NF-κB Signaling to Regulate Marginal Zone B Cell Development | The Journal of Immunology
![Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-020-00312-6/MediaObjects/41392_2020_312_Fig1_HTML.png)
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy
![Canonical NF-κB signaling is uniquely required for the long-term persistence of functional mature B cells | PNAS Canonical NF-κB signaling is uniquely required for the long-term persistence of functional mature B cells | PNAS](https://www.pnas.org/content/113/18/5065/F1.large.jpg)
Canonical NF-κB signaling is uniquely required for the long-term persistence of functional mature B cells | PNAS
![Frontiers | What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion? | Cell and Developmental Biology Frontiers | What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion? | Cell and Developmental Biology](https://www.frontiersin.org/files/Articles/470308/fcell-07-00154-HTML/image_m/fcell-07-00154-g001.jpg)
Frontiers | What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion? | Cell and Developmental Biology
![Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans - ScienceDirect Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0091674918302860-fx1.jpg)